Sabine Colnot
Paris, 75006, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Hepatocyte expression of fetal insulin receptor isoform contributes to the promotion of liver cancer through non-cell autonomous mechanisms.
Journal: bioRxiv : the preprint server for biology
Published: June 12, 2025
Neutralization of acyl coenzyme A binding protein for the experimental prevention and treatment of hepatocellular carcinoma.
Journal: Cell reports. Medicine
Published: March 13, 2024
Wnt, glucocorticoid and cellular prion protein cooperate to drive a mesenchymal phenotype with poor prognosis in colon cancer.
Journal: Journal of translational medicine
Published: February 12, 2024
DLK1/DIO3 locus upregulation by a β-catenin-dependent enhancer drives cell proliferation and liver tumorigenesis.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: December 01, 2023
Glutamine metabolism, a double agent combating or fuelling hepatocellular carcinoma.
Journal: JHEP reports : innovation in hepatology
Published: October 31, 2023
Antagonism between wild-type and mutant β-catenin controls hepatoblastoma differentiation via fascin-1.
Journal: JHEP reports : innovation in hepatology
Published: July 26, 2022
Deleting the β-catenin degradation domain in mouse hepatocytes drives hepatocellular carcinoma or hepatoblastoma-like tumor growth.
Journal: Journal of hepatology
Published: July 01, 2021
Maternal obesity: A severe risk factor in hepatocarcinogenesis?
Journal: Journal of hepatology
Published: May 20, 2020
Metabolic imaging assessing choline addiction in liver primary cancers predicts their oncogenotype and opens a new therapeutic avenue
Journal: Medecine sciences : M/S
Published: May 02, 2020
Expression of NKG2D ligands is downregulated by β-catenin signalling and associates with HCC aggressiveness.
Journal: Journal of hepatology
Published: December 18, 2019
Last Updated: 09/26/2026